Prescription drug · NDA
Tryngolza (Olezarsen sodium) NDC 71860-102
Olezarsen sodium 50 mg/.8mL · Injection, Solution · Subcutaneous · Ionis Pharmaceuticals, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71860-102-01 | 71860010201 | 1 SYRINGE, GLASS in 1 CARTON (71860-102-01) / .8 mL in 1 SYRINGE, GLASSMarketed from Jun 24, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Tryngolza
- Generic name (nonproprietary)
- olezarsen sodium
- Active ingredients
- Olezarsen sodium — 50 mg/.8mL
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Labeler
- Ionis Pharmaceuticals, Inc.NDC labeler code 71860
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 218614
- Marketing start
- Listing expires
- Other FDA classes
- Antisense (Chemical structure)Increased RNA Degradation (Physiologic effect)
- Identifiers
- Product ID 71860-102_55b4730e-4610-c0f2-e063-6294a90a90aeSPL ID 55b4730e-4610-c0f2-e063-6294a90a90aeSPL set ID 0f51aa8e-8475-8cf9-e063-6394a90a6848RxCUI 2701422, 2701428, 2746496, 2746499UNII NSY2BY6PSB
- Pharmacologic class
- APOC-III-directed RNA Interaction; Antisense Oligonucleotide
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N471860010201followed by a unit qualifier and the quantityPackage 71860-0102-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
TRYNGOLZA ® is indicated as an adjunct to diet: To reduce triglycerides (TG) in adults with familial chylomicronemia syndrome (FCS). To reduce TG and the risk of acute pancreatitis in adults with severe hypertriglyceridemia (sHTG: TG greater than or equal to 500 mg/dL). TRYNGOLZA is an apolipoprotein C-III (apoC-III)-directed antisense oligonucleotide (ASO) indicated as an adjunct to diet: To reduce triglycerides (TG) in adults with familial chylomicronemia syndrome (FCS). ( 1 ) To reduce TG and the risk of acute pancreatitis in adults with severe hypertriglyceridemia (sHTG: TG greater than or equal to 500 mg/dL). ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 71860-102
- What is NDC 71860-102?
- 71860-102 is the product NDC for Tryngolza (olezarsen sodium), Olezarsen sodium 50 mg/.8mL injection, solution, listed with the FDA by Ionis Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Tryngolza (Olezarsen sodium).
- What is the active ingredient?
- Olezarsen sodium.
- Who is the labeler?
- Ionis Pharmaceuticals, Inc., NDC labeler code 71860. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Tryngolza?
- 1 other product NDC are listed under this name. See all Tryngolza NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Tryngolza products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Tryngolzaolezarsen sodium | Olezarsen sodium 80 mg/.8mL | Injection, SolutionSubcutaneous | Ionis Pharmaceuticals, Inc. | 71860-101 | 71860-0101-01 |
Other NDCs under NDA 218614
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Tryngolzaolezarsen sodium | Olezarsen sodium 80 mg/.8mL | Injection, SolutionSubcutaneous | Ionis Pharmaceuticals, Inc. | 71860-101 |